GGrantIndex
Sort

15,842 grants matching pancreatic cancer

ANTITUMOR IMMUNITY INDUCED BY FUSION CELLS VACCINATION

$24,532
Boston University Medical Campus · R01 · FY2003 · CA

Evaluating outcomes for patients with primary-metastatic gastrointestinal cancer

$24,456
Jonathan Hernandez · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Proteomic Characterization of Pancreatic Neuroendocrine Tumors and Metastatic Progression

$24,454
Michael H. A. Roehrl · Sloan-Kettering Inst Can Research · R21 · FY2022 · CA

Origin, diversification and function of pancreatic cancer associated fibroblasts

$24,427
Lu Han · Medical University Of South Carolina · K99 · FY2024 · CA

The role of neuroendocrine transdifferentiation of pancreatic cancer cells on tumor progression and chemoresistance.

$24,327
Meghan Melinda Morrison Joly · Oregon Health & Science University · F32 · FY2018 · CA

The action of DDR2 in cancer-associated fibroblasts promotes ovarian cancer metastasis through increased arginase-1 activity.

$24,286
Favour Ayomide Akinjiyan · Washington University · F30 · FY2025 · CA

The Identification of a Novel MRP RNA-Protein Complex

$24,037
Kelly K Kopp · Northwestern University At Chicago · F31 · FY2008 · CA

Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers

$23,760
James Michael Pierce · University Of Georgia · U01 · FY2009 · CA

PancreasFest 2025: Pancreas Disease Across the Lifespan

$23,600
Randall Brand · University Of Pittsburgh At Pittsburgh · R13 · FY2025 · DK

Mouse Models and Cancer Stem Cells

$23,578
Inder Mohan Verma · Salk Institute For Biological Studies · P30 · FY2012 · CA

Mouse Models and Cancer Stem Cells

$23,577
Inder Mohan Verma · Salk Institute For Biological Studies · P30 · FY2011 · CA

Fatty Acylation of Hedgehog and Wnt proteins

$23,461
Marilyn D Resh · Sloan-Kettering Inst Can Research · R01 · FY2016 · GM

International Symposium of ALPD and Cirrhosis

$23,363
Hidekazu Tsukamoto · University Of Southern California · R13 · FY2020 · AA

A PHASE I/II STUDY OF AN ANTITUMOR VACCINATION IN PANCREATIC CANCER

$23,306
Laisvyde Statkute · Northwestern University At Chicago · M01 · FY2007 · RR

ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCER

$23,277
Howard S Hochster · New York University School Of Medicine · M01 · FY2007 · RR

Studying the initiation, progression and therapy of lung cancer in mouse models

$23,236
Martin McMahon · University Of Utah · R01 · FY2024 · CA

29 Radiation Oncology and Cancer Imaging

$23,220
Kristy Brock · University Of Tx Md Anderson Can Ctr · P30 · FY2024 · CA

07 Gastrointestinal Cancers

$23,220
Scott Kopetz · University Of Tx Md Anderson Can Ctr · P30 · FY2024 · CA

Stromal IL-6/Jak-STAT signaling and pancreatitis

$23,100
Michael C Ostrowski · Ohio State University · R21 · FY2017 · AI

Systems Approach to Dynamic Interplay between cAMP/PKA and ERK Signaling

$22,935
Clara Anne Posner · University Of California, San Diego · F31 · FY2023 · CA

Evaluating outcomes for patients with primary-metastatic gastrointestinal cancer

$22,923
Jonathan Hernandez · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Targeting MUC1-induced Tumor-stromal Metabolic Cross-talk in Pancreatic Cancer

$22,890
Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2015 · CA

Novel Biodegradable Nanoadjuvants for Immunotherapy of Pancreatic Cancer

$22,754
Maria P Torres-Gonzalez · Iowa State University · F31 · FY2007 · CA

Acetaldehyde and Epithelial Junctions: Role of PP2A and Occludin Phosphorylation

$22,747
Mitzi Lee Dunagan · University Of Tennessee Health Sci Ctr · F31 · FY2011 · AA

IGF::OT::IGF PROGRAM HEIGHT AND WEIGHT DATA TO CALCULATE A VALID MEASURE OF BODY MASS INDEX. PERIOD OF PERFORMANCE: 09/19/2016 - 09/18/2017

$22,552
Michele West · University Of Iowa · N01 · FY2016 · CA